Esophageal Balloon Calibration in Assisted Ventilation Mode (EBC-PSV+Sigh)

September 3, 2019 updated by: Gianmaria Cammarota, Azienda Ospedaliero Universitaria Maggiore della Carita

Esophageal Balloon Calibration During Assisted Ventilation Modes and Sigh: a Feasibility Study

Esophageal balloon calibration (EBC) has been proposed during controlled mechanical ventilation in intubated patients in order to optimize esophageal pressure (Pes) signal. Actually, at our knowledge, no data exist about EBC during assisted ventilatory modes such as Pressure Support Ventilation (PSV). The primary endpoint of the present investigation is to assess the feasibility of EBC during PSV and PSV plus Sigh.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Assisted ventilatory modes, nowadays, have been proved to reduce complications related to controlled mechanical ventilation. With these modes, ventilatory cycling is under the patient's control to an extent depending on the type of ventilatory modality.

Sigh improves oxygenation and lung mechanics during pressure control ventilation and pressure support ventilation (PSV) in patients with acute respiratory distress syndrome.

In order to better quantify the effects of both PSV and PSV plus Sigh on respiratory mechanics, the esophageal pressure monitoring could be helpful. However, esophageal pressure (Pes) assessment requires esophageal ballon calibration (EBC) as demonstrated in intubated patients under controlled mechanical ventilation.

At our knowledge, no data exist about EBC during assisted ventilatory modes. The primary aim of the present study is to evaluate the effects of PSV and PSV plus Sigh ventilation on esophageal balloon best volume in patients admitted to the intensive care unit for acute respiratory failure.

.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Novara, Italy, 28100
        • A.O.U Maggiore della Carità

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients older than 18 years;
  • undergoing mechanical ventilation for more than 24 hours (in volume-controlled mode) and with readiness to run assisted ventilation;

Exclusion Criteria:

  • severe COPD with air trapping clinical suspicion;
  • hemodynamic instability requiring inotropic or vasopressor support;
  • any contraindications to esophageal catheter positioning

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: EBC-assisted
A nasogastric tube, equipped with esophageal and gastric balloons, will be inserted in each patient enrolled in the study. After definitive catheter positioning has been obtained, Esophageal ballon calibration will be run in volume-controlled ventilation, pressure support ventilation and sigh + pressure support ventilation.

After definitive catheter positioning, esophageal balloon calibration will be performed in:

  1. volume-controlled mode with tidal volume set to obtain 6-8 lm/kg of ideal body weight (reference),
  2. pressure support ventilation (PSV) with support set to obtain a tidal volume ranging between 6-8 ml/kg of ideal body weight at equal PEEP of volume control mode (PSV baseline);
  3. PSV + sigh ventilation (sigh setting: total inspiratory pressure equal to 35 cmH2O at a rate of 1/ minute; inspiratory time equal to 4 seconds).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effects of ventilatory mode on calibrated esophageal ballon best volume
Time Frame: Over 120 minutes in PSV
Evaluation of changes of esophageal balloon best volume (ml) induced by ventilatory modes
Over 120 minutes in PSV
Number of patients in who esophageal balloon calibration is performed (feasibility) during PSV + Sigh
Time Frame: Over 30 minutes in PSV + Sigh
Evaluate the feasibility of esophageal catheter calibration during assisted ventilation modes during PSV + Sigh
Over 30 minutes in PSV + Sigh

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of respiratory mechanics indices in PSV
Time Frame: over 30 minutes in PSV
lung, chest wall and respiratory system elastance (cmH2O/l)
over 30 minutes in PSV
Changes of respiratory mechanics indices in PSV + sigh
Time Frame: over 30 minutes in PSV + Sigh
lung, chest wall and respiratory system elastance (cmH2O/l)
over 30 minutes in PSV + Sigh
Gas exchange
Time Frame: over 30 minutes during each trial
PaCO2, Ph and blood oxygenation (PaO2) will be obtained performing ABGs.
over 30 minutes during each trial

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gianmaria Cammarota, MD,PhD, "Maggiore della Carità" Hospital, Novara

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 15, 2018

Primary Completion (ACTUAL)

August 1, 2019

Study Completion (ACTUAL)

August 1, 2019

Study Registration Dates

First Submitted

October 19, 2018

First Submitted That Met QC Criteria

October 24, 2018

First Posted (ACTUAL)

October 26, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 4, 2019

Last Update Submitted That Met QC Criteria

September 3, 2019

Last Verified

December 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on EBC-assisted

Subscribe